Toronto (June 16, 2015) — Borden Ladner Gervais (BLG) released the second edition of Life Signs, an instructive look at the life sciences legal trends shaping the Canadian industry at BIO2015.

The report arrives at a critical time — the convergence of scientific innovation, legislation, an aging demographic and investors looking for new opportunities. BLG’s Life Signs reviews how the biotechnology sector in Canada will transform in the years to come.

BLG has a long history working with the life sciences community in Canada. The firm has one of Canada’s leading life sciences practices with considerable experience in the protection of intellectual property, financing, commercialization, licensing, regulatory compliance, advocacy and dispute resolution.

Life Signs is a must read for anyone operating in the biotech space. Highlights include: 

  • An overview of the shifting ground of patentable subject matter in Canada
  • Regulatory trends that include recent amendments to the Food & Drugs Act and a regulatory framework for orphan drugs
  • Protecting biotech businesses against departing employees
  • Important new principles in contractual negotiations
  • The impact of precedent setting Supreme Court of Canada cases
  • A review of important changes to the Canadian Patent Practice

In addition to the observations made by BLG’s biotechnology team, the report also includes the analysis of national and regional associations. Industry partners: BIOTECanada, Rx&D, BioNova, Life Sciences Ontario and Life Sciences BC all share their view into Canada’s evolving biotech industry.

About Borden Ladner Gervais LLP

Borden Ladner Gervais LLP (BLG) is a leading, national, full-service Canadian law firm focusing on business law, commercial litigation and arbitration, and intellectual property solutions for our clients. BLG is one of the country’s largest law firms with more than 725 lawyers, intellectual property agents and other professionals in five cities across Canada. We assist clients with their legal needs, from major litigation to financing to trademark and patent registration.

— 30 —

For more information or to arrange an interview, please contact:

Eusis Dougan-McKenzie
Borden Ladner Gervais LLP

Tia Thomas
Environics Communications Inc.